Back to search
S3060IntroducedRhode Islandsenate

Requires pharmacy benefit managers to apply for a certificate of authority from the department of business regulation to operate such a business in this state. Empowers director of DBR to oversee all pharmacy benefit managers and penalize violations.

View official bill

Plain English Summary

AI-generated

Plain-English Summary

This bill would require pharmacy benefit managers (PBMs) to obtain official permission — called a "certificate of authority" — from Rhode Island's Department of Business Regulation (DBR) before they can operate in the state. PBMs are companies that act as middlemen between insurance companies, pharmacies, and drug manufacturers. They play a major role in determining which drugs are covered by insurance plans and how much people pay for their prescriptions.

Under this bill, the DBR would gain the authority to oversee and regulate these companies, making sure they follow state rules. If a PBM breaks those rules, the DBR director would have the power to investigate and impose penalties. Essentially, this bill brings PBMs under a formal licensing and oversight system, similar to how other businesses in the insurance industry are already regulated.

This bill would affect a wide range of Rhode Islanders — including patients, pharmacies, and health insurers — because PBMs influence prescription drug costs and access. Pharmacies, especially independent ones, could see changes in how their reimbursements and contracts are handled and monitored. Patients might benefit if stronger oversight leads to more transparent or fair drug pricing practices. The bill is currently in the early stages of the legislative process, having been referred to the Senate Health and Human Services Committee for further review.

This summary is AI-generated for informational purposes. Always refer to the official bill text for legal accuracy.

Sponsors

P
Peter AppollonioD
M
Melissa MurrayD
V
Valarie LawsonD
F
Frank CicconeD
D
David TikoianD
M
Matthew LaMountainD

Legislative History

Committee recommended measure be held for further study

Mar 26, 2026

Scheduled for hearing and/or consideration (03/26/2026)

Mar 20, 2026

Introduced, referred to Senate Health and Human Services

Mar 12, 2026